Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment
Amir Arastehfar, Agostinho Carvalho, Frank L. van de Veerdonk, et al.
Journal of Fungi (2020) Vol. 6, Iss. 2, pp. 91-91
Open Access | Times Cited: 380

Showing 26-50 of 380 citing articles:

The one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda
Paul E. Verweij, John A. Lucas, Maiken Cavling Arendrup, et al.
Fungal Biology Reviews (2020) Vol. 34, Iss. 4, pp. 202-214
Open Access | Times Cited: 102
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy
Christoph Zurl, Martin Hoenigl, Eduard Schulz, et al.
Journal of Fungi (2021) Vol. 7, Iss. 2, pp. 88-88
Open Access | Times Cited: 98
Pan-Echinocandin-Resistant Candida glabrata Bloodstream Infection Complicating COVID-19: A Fatal Case Report
Brunella Posteraro, Riccardo Torelli, Antonietta Vella, et al.
Journal of Fungi (2020) Vol. 6, Iss. 3, pp. 163-163
Open Access | Times Cited: 84
Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients
Maryam Roudbary, Sunil Kumar, Awanish Kumar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 9, pp. 720-720
Open Access | Times Cited: 81
Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study
Stefan Hatzl, Alexander C. Reisinger, Florian Posch, et al.
Critical Care (2021) Vol. 25, Iss. 1
Open Access | Times Cited: 79
COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory
Andrew M. Borman, M. Dean Palmer, Mark Fraser, et al.
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 1
Open Access | Times Cited: 78
COVID-19—Lessons Learned and Questions Remaining
Ferric C. Fang, Constance A. Benson, Carlos del Rı́o, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 12, pp. 2225-2240
Open Access | Times Cited: 76
Candidemia among Iranian Patients with Severe COVID-19 Admitted to ICUs
Amir Arastehfar, Tahmineh Shaban, Hossein Zarrinfar, et al.
Journal of Fungi (2021) Vol. 7, Iss. 4, pp. 280-280
Open Access | Times Cited: 74
Invasive aspergillosis in critically ill patients: Review of definitions and diagnostic approaches
Jeffrey D. Jenks, Hannah Nam, Martin Hoenigl
Mycoses (2021) Vol. 64, Iss. 9, pp. 1002-1014
Open Access | Times Cited: 73
COVID-19 Impairs Immune Response to Candida albicans
Dominique Moser, Katharina Biere, Bing Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options
Laura Nunes Silva, Thaís P. Mello, Lívia S. Ramos, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 22, pp. 1951-1957
Closed Access | Times Cited: 70
Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis
Woon H. Chong, Biplab K. Saha, Kristoffer Neu
Infection (2021) Vol. 50, Iss. 1, pp. 43-56
Open Access | Times Cited: 68
Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis
Salman Hussain, Abanoub Riad, Ambrish Singh, et al.
Journal of Fungi (2021) Vol. 7, Iss. 11, pp. 985-985
Open Access | Times Cited: 66
VDA-RWLRLS: An anti-SARS-CoV-2 drug prioritizing framework combining an unbalanced bi-random walk and Laplacian regularized least squares
Ling Shen, Fu‐Xing Liu, Li Huang, et al.
Computers in Biology and Medicine (2021) Vol. 140, pp. 105119-105119
Open Access | Times Cited: 65
Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic
Ayushi Sharma, Anjana Goel
Folia Microbiologica (2022) Vol. 67, Iss. 3, pp. 363-387
Open Access | Times Cited: 62
Navigating the Uncertainties of COVID-19–Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis
Frédéric Lamoth, Russell E. Lewis, Thomas J. Walsh, et al.
The Journal of Infectious Diseases (2021)
Open Access | Times Cited: 60
Pathogenesis of Respiratory Viral and Fungal Coinfections
Fabián Salazar, Elaine Bignell, Gordon D. Brown, et al.
Clinical Microbiology Reviews (2021) Vol. 35, Iss. 1
Open Access | Times Cited: 59
COVID-19-Associated Pulmonary Aspergillosis (CAPA)
George Dimοpoulos, Maria Panagiota Almyroudi, Pavlos Myrianthefs, et al.
Journal of Intensive Medicine (2021) Vol. 1, Iss. 2, pp. 71-80
Open Access | Times Cited: 55
COVID-19-Associated Candidiasis: Possible Patho-Mechanism, Predisposing Factors, and Prevention Strategies
Nafisa Ahmed, Maiesha Samiha Mahmood, Md. Asad Ullah, et al.
Current Microbiology (2022) Vol. 79, Iss. 5
Open Access | Times Cited: 55
CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models
Michelle Seif, Tamara Katharina Kakoschke, Frank Ebel, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Closed Access | Times Cited: 55
Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions
Matthias Egger, Linda Bussini, Martin Hoenigl, et al.
Journal of Fungi (2022) Vol. 8, Iss. 4, pp. 390-390
Open Access | Times Cited: 40
Fungal infection profile in critically ill COVID-19 patients: a prospective study at a large teaching hospital in a middle-income country
Essamedin M. Negm, Mohamed Sorour Mohamed, Rehab Ahmed Rabie, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 32
Race and ethnicity: Risk factors for fungal infections?
Jeffrey D. Jenks, Chioma Inyang Aneke, Mohanad Al‐Obaidi, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 1, pp. e1011025-e1011025
Open Access | Times Cited: 29
COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance
Mohammad Javad Najafzadeh, Tahmineh Shaban, Hossein Zarrinfar, et al.
Medical Mycology (2024) Vol. 62, Iss. 4
Closed Access | Times Cited: 7
Is the COVID-19 Pandemic a Good Time to Include Aspergillus Molecular Detection to Categorize Aspergillosis in ICU Patients? A Monocentric Experience
Jean‐Pierre Gangneux, Florian Reizine, Hélène Guegan, et al.
Journal of Fungi (2020) Vol. 6, Iss. 3, pp. 105-105
Open Access | Times Cited: 65

Scroll to top